Jazz Pharmaceuticals (JAZZ) Minority Interest (2014 - 2015)
Jazz Pharmaceuticals' (JAZZ) quarterly Minority Interest came in at $14000.0 in Q3 2015, down 84.44% year-on-year from $90000.0 in Q3 2014, and down 74.55% quarter-over-quarter from $55000.0 in Q2 2015.
Jazz Pharmaceuticals (JAZZ) Minority Interest (2014 - 2015) Analysis & Trends
Jazz Pharmaceuticals' Minority Interest history runs 2 years deep, the most recent figure standing at $14000.0 for Q3 2015.
- On a quarterly basis, Minority Interest fell 84.44% year-over-year to $14000.0 in Q3 2015; TTM through Sep 2015 was $14000.0, a 84.44% decrease from a year earlier, with the FY2014 full-year figure at $64000.0, changed N/A from the prior year.
- Minority Interest retreated to $14000.0 in Q3 2015 per JAZZ's latest filing, from $55000.0 in the prior quarter.
- Across five years, Minority Interest topped out at $17.6 million in Q1 2014 and bottomed at $14000.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 14,000.00 |
| Jun 30, 2015 | 55,000.00 |
| Mar 31, 2015 | 54,000.00 |
| Dec 31, 2014 | 64,000.00 |
| Sep 30, 2014 | 90,000.00 |
| Jun 30, 2014 | 396,000.00 |
| Mar 31, 2014 | 17.62 Mn |